Effective treatment for metabolic acidosis, suitable for conditions such as severe renal disease, uncontrolled diabetes, and circulatory insufficiency.
Useful in managing drug intoxications, including barbiturates, by promoting dissociation of the barbiturate-protein complex.
Indicated for extracorporeal circulation of blood, cardiac arrest, and severe primary lactic acidosis.
Manufactured by APP Pharmaceuticals, ensuring high-quality and reliable treatment.
Comes in a single-dose 50 mL vial, providing a convenient and precise dosage.
